EUVIMEDEUVIMED entdecken
Crossref

Enhancing Tranexamic Acid Penetration through AQP‐3 Protein Triggering via ZIF‐8 Encapsulation for Melasma and Rosacea Therapy

Jie Tang iD, Yu Li, Xuefeng Hu, Wei Hua, Haoning Xu, Li Li, Fujian Xu iD

Advanced Healthcare Materials · 2024

DOI: 10.1002/adhm.202304189 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2024. Verfasst von Jie Tang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Cosmetics Safety and Efficacy Evaluation Center, West China Hospital, Sichuan University, Chengdu, 610041, China. Hauptthemen laut MEDLINE: Tranexamic Acid, Rosacea, Aquaporin 3, Melanosis. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 65 Literaturangaben. Gefördert von: Natural Science Foundation of Sichuan Province, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The systemic use of tranexamic acid (TA) as an oral drug can bring adverse reactions, while intradermal injection leads to pain and a risk of infection. Moreover, it is difficult for highly hydrophilic TA to penetrate the skin barrier that contains lots of hydrophobic lipid compounds, which poses enormous restrictions on its topical application. Current transdermal TA delivery strategies are suffering from low drug load rates, plus their synthesis complexity, time‐consumption, etc. adding to the difficulty of TA topical application in clinical therapeutics. To increase the penetration of TA, a novel approach using TA‐loaded ZIF‐8 (TA@ZIF‐8) is developed. The encapsulation efficiency of TA@ZIF‐8 reaches ≈25% through physical adsorption and chemical bonding of TA indicates by theoretical simulation and the improved TA penetration is elevated through activating the aquaporin‐3 (AQP‐3) protein. Additionally, in vivo and in vitro experiments demonstrate the preponderance of TA@ZIF‐8 for penetration ability and the advantages in intracellular uptake, minor cytotoxicity, and inhibition of melanogenesis and inflammatory factors. Moreover, clinical trials demonstrate the safety and efficacy of TA@ZIF‐8 in the treatment of melasma and rosacea. This work presents a potential topical application of TA, free from the safety concerns associated with systemic drug administration.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tranexamic AcidRosaceaAquaporin 3MelanosisHumansAnimalsMiceAdministration, CutaneousFemaleMetal-Organic FrameworksSkinMale

Stichwörter der Autor:innen

anti‐inflammationanti‐pigmentationdrug penetrationmelasmarosacea

Substanzen

Tranexamic AcidAquaporin 3Metal-Organic Frameworks

Autor:innen und Institutionen

  • Cosmetics Safety and Efficacy Evaluation Center, West China Hospital, Sichuan University, Chengdu, 610041, China.
  • NMPA Key Laboratory for Human Evaluation and Big Data of Cosmetics, Sichuan University, Chengdu, 610041, China.
  • Department of Dermatology, West China Hospital, Sichuan University, Chengdu, 610041, China.
  • West China School of Basic Medical Sciences & Forensic Medicine, Sichuan University, Chengdu, 610041, China.
  • School of Chemistry and Environment, Southwest Minzu University, Chengdu, 610225, China.

ORCID-Profile: Jie Tang, Fujian Xu

Förderung

  • Natural Science Foundation of Sichuan Province
  • National Natural Science Foundation of China

Zitieren

APA

Tang, J., Li, Y., Hu, X., Hua, W., Xu, H., Li, L., & Xu, F. (2024). Enhancing Tranexamic Acid Penetration through AQP‐3 Protein Triggering via ZIF‐8 Encapsulation for Melasma and Rosacea Therapy. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202304189

Vancouver

Tang J, Li Y, Hu X, Hua W, Xu H, Li L, et al. Enhancing Tranexamic Acid Penetration through AQP‐3 Protein Triggering via ZIF‐8 Encapsulation for Melasma and Rosacea Therapy. Advanced Healthcare Materials. 2024. doi:10.1002/adhm.202304189

BibTeX
@article{Tang2024,
  author = {Tang, Jie and Li, Yu and Hu, Xuefeng and Hua, Wei and Xu, Haoning and Li, Li and Xu, Fujian},
  title = {Enhancing Tranexamic Acid Penetration through AQP‐3 Protein Triggering via ZIF‐8 Encapsulation for Melasma and Rosacea Therapy},
  journal = {Advanced Healthcare Materials},
  year = {2024},
  doi = {10.1002/adhm.202304189}
}
Kostenlos starten →